Afrezza (Technosphere insulin inhalation powder)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Afrezza (Technosphere insulin inhalation powder), covering 2013-01-25 to 2013-01-25. Get the full timeline:
Most recent: Clinical Trial Update: Comparison of Technosphere Insulin Inhalation Powder & Subcutaneous Rapid-Acting Analog in Subjects With Type 1 Diabetes [Phase 1]